GGrantIndex
← Leaderboards

Tissuetech, Inc.

Miami, FL

Compare ↔
$14,825,888
Total funding
16
Grants

Funding over time

peak $1.8M · FY200520
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$14,825,888 · 16

By mechanism

R01$7,433,571 · 2
R44$6,077,584 · 6
R43$1,314,733 · 8

Investigators at Tissuetech, Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Safety and Efficacy of Single-use Cliradex Pads for Ocular Mites$637,507
R44 · FY2014 · EY
Engineering of Human Corneal Endothelial Grafts$618,105
R44 · FY2014 · EY
Engineering of Human Corneal Endothelial Grafts$601,809
R44 · FY2015 · EY
Safety and Efficacy of Single-use Cliradex Pads for Ocular Mites$552,166
R44 · FY2012 · EY
Prevention of Proliferative Vitreoretinopathy by HC-HA/PTX3$549,979
R44 · FY2017 · EY
Phase II: Anti-inflammatory and Anti-scarring Actions of Amniotic Membrane Extra$497,475
R44 · FY2011 · EY
Prevention of Proliferative Vitreoretinopathy by HC-HA/PTX3$454,715
R44 · FY2016 · EY
Phase II: Anti-inflammatory and Anti-scarring Actions of Amniotic Membrane Extra$438,105
R44 · FY2010 · EY
Amniotic Membrane versus Pericardium in Reducing Glaucoma Drainage Tube Exposure$395,538
R44 · FY2012 · EY
Amniotic Membrane versus Pericardium in Reducing Glaucoma Drainage Tube Exposure$395,020
R44 · FY2013 · EY
Regulation of Limbal Epithelial Stem Cells by the Native Niche$384,456
R01 · FY2012 · EY
Regulation of Limbal Epithelial Stem Cells by the Native Niche$384,456
R01 · FY2011 · EY
Regulation of Limbal Epithelial Stem Cells by the Native Niche$376,766
R01 · FY2014 · EY
Regulation of Limbal Epithelial Stem Cells by the Native Niche$376,766
R01 · FY2015 · EY
Quiescence of Limbal Epithelial Stem Cells$375,910
R01 · FY2020 · EY
Quiescence of Limbal Epithelial Stem Cells$375,910
R01 · FY2018 · EY
Quiescence of Limbal Epithelial Stem Cells$375,910
R01 · FY2017 · EY
Quiescence of Limbal Epithelial Stem Cells$375,910
R01 · FY2019 · EY
EX VIVO EXPANSION OF LIMBAL EPITHELIAL STEM CELLS$371,030
R01 · FY2002 · EY
DEVELOPMENT OF SUTURELESS AMNIOTIC MEMBRANE GRAFT$368,160
R44 · FY2007 · EY